Home  Clinical trials Products in Development AZD2295
|
|
A number of clinical trials with AZD2295 Ongoing studies are currently in progress.
More studies will be added in due course. Additional AZD2295 Ongoing study information is available on ClinicalTrials.gov. | Study Number | Study Phase | Start Date | Recruitment Status | | D0180C00018 | Phase I | 9 Jan 2008 | Recruiting | | Open label Positron Emission Tomography (PET) study with [11C]AZD2995 and [11C]AZD2184, candidate PET ligands for β amyloid, to determine and compare in vivo brain uptake and distribution in healthy volunteers and patients with Alzheimer’s Disease |
|
|
|
|